TrialPloS one2012

Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients.

Antonio Rivero-Juárez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.